Gordon Fox • May 13, 2025
Decisions in HCM: Understanding Risk

by Gordon Fox: 3rd in a series

Risk is a concept we have encountered many times during our HCM journeys, and we want to help you understand it and its implications. We'll explain what risk means and how risks are estimated, and we'll discuss how to use these risk estimates in making decisions about HCM care. Though it sounds like a simple idea, risk can be complicated; we will do our best to make this series readable for all HCM patients.

The idea of risk

First, let's clarify how some numbers work, with an example of the risk for sudden cardiac arrest (SCA). Many of us would like to know the chance of this happening to us in the next five years. In an imaginary world, we could do this experiment: make many (say, 100) copies of yourself, and over the next five years, count how many have an SCA. Let's say that 3 have SCAs. Then, a good estimate of your risk is 3/100. We could express that in several other ways: for instance, as a decimal (0.03) or a percentage (3% - remember that a percent sign means "out of 100"). 

How do scientists estimate risk?

OK, great, but there are two problems. First, we can't make copies of you (and unless they all live exactly your life over five years, their risks might be different anyway). And second, well, this would only tell us what your risk was after five years when we want to know about the next five years! 


Here's where scientists and statisticians get into the act. We can study the records of many HCM patients and ask if characteristics tend to differ between those people who have SCAs and those who don't. For example, for each group, they ask how old are they, how many of them have had ventricular tachycardia (LINK), and how thick is their septum? By doing this, we can develop a prediction: if a person has your characteristics, their risk is about (let's say) 4/100. It's not the same number as we got from our experiment in cloning you, but it isn't very different, and it may even be closer to reality. 

Risk is estimated for a period of time

Let's be clear: this number estimates the chance of the harmful event (in this case, SCA) happening over the next five years. This is what healthcare workers usually mean when they talk of risk. Do notice that we named a specific period. If someone tells you, "Your risk of X (some bad thing) happening is 10%," you should always ask, "Over what period?" They don't mean your risk of it ever happening is 10% because that is not meaningful and can't be calculated. 

Risk and money

There's another way the word "risk" is sometimes used. It's similar to this but a little more complicated. Imagine that you are trying to figure out how much money you might need if you need to have a myectomy. This is often worded as how much (financial) risk you could have. A way to think of it is the chance you'll need a myectomy, times the cost of a myectomy if you do need one. If you can make plans like this, it is a perfectly good thing to do. (By the way, this combined idea of risk is exactly what most insurers and employers mean: how much money something might  cost them if it happens.) But in these blog posts, we'll use the simpler approach: when we say "risk," we mean the chance that something will happen, and if we need to talk about costs, we'll do that separately.


Interpreting a risk estimate

OK, you've been told your risk of having an SCA is 4% over the next five years. Is that a lot or a little? There is no general answer to this because some of us like to do things like go bungee jumping, while others won't get near any steep place if they can avoid it. You need to decide how much risk you're willing to accept. It may help to realize that 4% over five years means another 4% (at least) over the next five years - in other words, 8% over ten years, which sounds like a much larger risk.


Incidentally, you must do more than keep adding these numbers up. Your risk over 20 years isn't twice your risk over ten years because you'll be older, and your heart and other factors will change over that time. There's a sensible reason risks like these are usually estimated only for a few years.


As we will see in a later post in this series, there is more to understand. We are confident that all our readers will be able to understand it.

Read Part 2:
Decisions in HCM: Why Are They So Hard?


HCMA Blog

By Lisa Salberg July 3, 2025
Summer, greetings to all our big-hearted friends As July approaches, our focus is already on the fall and preparing for some major events, including our annual meeting coming up in October. July will also find us on the west coast in Seattle conducting a regional patient education meeting as part of our big-hearted warrior tour. We have been following the generic drug quality issue in the United States very closely and encourage you to watch the series starting with our Hill briefing in April and following with the additional webinars with our partners at Medshadow and the People's Pharmacy, and of course the ProPublica series of articles. See them all here . We are happy to have a new team member on board - we welcome Pam as our coordinator of both our All Hearts Collaborative and Hearts and Minds project. Over the next few months, you're going to be learning more about these two amazing initiatives and how we are working to provide better services for big hearts regardless of where you live, so we are meeting all of our big-hearted friends where they are. Please stay tuned for updates from these projects coming soon. We are also creating new volunteer opportunities and engagements that we hope will make it easier for you to participate in spreading the message of the importance of diagnosis, the importance of community readiness related to CPR and AED use and, of course, helping patients get to their ultimate diagnosis and getting them on the proper treatment pathways. This July I would like to recognize all of the special birthdays in my family, including HCMA Center of Excellence coordinator, Stacey Titus-brown and my daughter Rebecca Salberg. It's a milestone birthday for Becca - it’s hard to believe I have a 30-year-old child. Wishing you all a happy and healthy summer. Go build some memories!
An official seal in black  & red with white letters that say HCMS Recognized Centers of Excellence
By Sabrina Cuddy July 3, 2025
Getting HCM care at a HCMA Recognized Center of Excellence has a positive impact on patient's outcomes. Find out why in the post by Health Educator Sabrina Cuddy
By Erica Friedman June 26, 2025
Investigative journalists Debbie Cenziper, Megan Rose, Brandon Roberts and Irena Hwang from Pro Publica and NPR have concluded a 14-month long investigation into the quality of generic drugs coming into the United States from overseas. Among the many voices that spoke up for American patients was HCMA Founder and CEO, Lisa Salberg who has felt the effects of low-quality drugs personally. Salberg believes that fixing this problem is something we can do, even in this time, when even health care is highly politicized. Read the key takeaways from ProPublica’s 14-month investigation into the FDA’s oversight of foreign drugmakers in Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs .
More Posts